Implications of antibiotic resistance in the management of Helicobacter pylori infection: Canadian Helicobacter study group

Canadian Journal of Gastroenterology

Volumn 14, Issue 10, 2000, Pages 862-868

  Hunt, R H ^a   Smaill, F M ^a   Fallone, C A ^a   Sherman, P M ^a   van Zanten, S J V ^a   Thomson, A B R ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antibiotic resistance; Clarithromycin; Helicobacter pylori; Metronidazole

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BACTERIAL RNA; BETA LACTAMASE; BISMUTH SALICYLATE; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE BISMUTH CITRATE; RIBOSOME RNA; TETRACYCLINE; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; CANADA; CLINICAL PROTOCOL; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MANAGEMENT; DRUG EFFICACY; DRUG MONITORING; DUODENUM MUCOSA; ERADICATION THERAPY; GASTROINTESTINAL INFECTION; GEOGRAPHIC PATHOLOGY; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; INFORMATION PROCESSING; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PEPTIC ULCER; PREVALENCE; PRIORITY JOURNAL; STOMACH MUCOSA; STRAIN DIFFERENCE; TREATMENT FAILURE; TREATMENT PLANNING;

EID: 0034507230     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2000/601256     Document Type: Article

References (39)

1. Consensus Conference Participants. Canadian Helicobacter pylori Consensus Conference
2. Canadian Helicobacter pylori Consensus Conference update: Infections in adults
3. Canadian Helicobacter Study Group Consensus Conference on the Approach to Helicobacter pylori Infection in Children and Adolescents
4. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report
5. Report of the 1997 Asia Pacific Consensus Conference on the management of Helicobacter pylori infection
6. The MACH2 study: Role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies
7. Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: The MACH2 study
8. Rationale for the choice of antibiotics for the eradication of Helicobacter pylori
9. A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates
10. Antibiotic resistance in Helicobacter pylori: Implications for therapy
11. Clinical relevance of resistant strains of Helicobacter pylori: A review of current data
12. Predicting treatment failure with PPI-based triple therapies in metronidazole-resistant H. pylori infections: A model based on trial meta-analysis data
13. Cumulative 10-year risk of symptomatic duodenal and gastric ulcer in patients with or without chronic gastritis
14. Long-term risk of peptic ulcer disease in people with Helicobacter pylori infection - A community based study
15. Helicobacter pylori infection as a cause of gastritis, duodenal ulcer, gastric cancer and nonulcer dyspepsia: A systematic overview
16. Helicobacter pylori in peptic ulcer disease
17. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
18. An international association between Helicobacter pylori and gastric cancer
19. Modelling cost-effectiveness of Helicobacter pylori screening to prevent gastric cancer: A mandate for clinical trials
20. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer
21. Infection with Helicobacter pylori
22. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect
23. Hp and pH - The relevance of gastric acid to the treatment of Helicobacter pylori infection
24. Different penicillin-binding protein profiles in amoxicillin-resistant Helicobacter pylori
25. Amoxycillin tolerance in Helicobacter pylori
26. Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection
27. Sensitivity of amoxicillin-resistant Helicobacter pylori to other penicillins
28. In-vitro susceptibility of Helicobacter pylori to ampicillin, clarithromycin, metronidazole and omeprazole
29. Antibiotic susceptibilities of Helicobacter pylori strains isolated in the Province of Alberta
30. Treatment after failure: The problem of "non-responders"
31. The importance of clarithromycin dose in the management of Helicobacter pylori infection: A meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole
32. Susceptibility of Canadian strains of Helicobacter pylori to metronidazole and clarithromycin using four assay methods
33. Assessment of metronidazole susceptibility in Helicobacter pylori: Statistical validation and error rate analysis of breakpoints determined by the disk diffusion test
34. Metabolic activities of metronidazole-sensitive and -resistant strains of Helicobacter pylori: Repression of pyruvate oxidoreductase and expression of isocitrate lyase activity correlate with resistance
35. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations
36. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance
37. H. pylori resistance to macrolides increases, to imidazole remains stable